Literature DB >> 29765142

Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.

Jiyeon Hyeon1, Boram Lee2,3, So-Hyun Shin1, Hae Yong Yoo3, Seok Jin Kim4, Won Seog Kim4, Woong-Yang Park5, Young-Hyeh Ko6.   

Abstract

Gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue is a distinct entity in that Helicobacter pylori infection plays the most important causative role in the development of the disease. To investigate the genomic alteration in gastric marginal zone lymphoma that was resistant to the H. pylori eradication therapy, we analyzed 19 cases of the gastric marginal zone lymphoma using fluorescence in situ hybridization for MALT1, BCL10 rearrangement, and targeted sequencing using an Illumina platform. Major genetic alterations affected genes involved in nuclear factor (NF)-κB pathway activation and included MALT1 rearrangement (39%), and somatic mutations of TRAF3 (21%), TNFAIP3 (16%), and NOTCH1 (16%). In the MALT1 rearrangement-negative group, disruptive somatic mutations of TRAF3 were the most common alterations (4/12, 33%), followed by somatic mutations of TNFAIP3 (3/12, 25%), and NOTCH1 (3/12, 25%). The present study confirms that genes involved in activation of NF-κB-signaling pathways are a major driver in oncogenesis of H. pylori eradication-resistant gastric marginal zone lymphoma and revealed that TRAF3 mutation is a major contributor in MALT1 rearrangement-negative gastric marginal zone lymphoma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29765142     DOI: 10.1038/s41379-018-0064-0

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Elevated Choline Kinase α-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.

Authors:  Samantha Gokhale; Wenyun Lu; Sining Zhu; Yingying Liu; Ronald P Hart; Joshua D Rabinowitz; Ping Xie
Journal:  J Immunol       Date:  2019-12-11       Impact factor: 5.422

2.  Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.

Authors:  Bryan Rea; Yen-Chun Liu; Alanna Maguire; Lorinda A Soma; Chris M Bacon; Michael G Bayerl; Molly H Smith; Michael T Barrett; Steven H Swerdlow; Sarah E Gibson
Journal:  Mod Pathol       Date:  2021-12-24       Impact factor: 8.209

3.  High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer.

Authors:  Seung Eun Lee; Hye Seung Lee; Kyoung-Yeon Kim; Jung-Hoon Park; Hanseong Roh; Ha Young Park; Wan-Seop Kim
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

Review 4.  Manifold role of ubiquitin in Helicobacter pylori infection and gastric cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Cell Mol Life Sci       Date:  2021-04-07       Impact factor: 9.261

Review 5.  Recent Advances in the Genetic of MALT Lymphomas.

Authors:  Juan José Rodríguez-Sevilla; Antonio Salar
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

Review 6.  KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.

Authors:  Elena Vendramini; Riccardo Bomben; Federico Pozzo; Tamara Bittolo; Erika Tissino; Valter Gattei; Antonella Zucchetto
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

7.  Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia.

Authors:  Jang Ho Cho; Joon-Ho Shim; Sang Eun Yoon; Hee-Jin Kim; Sun-Hee Kim; Young Hyeh Ko; Seung-Tae Lee; Kihyun Kim; Won Seog Kim; Seok Jin Kim
Journal:  Korean J Intern Med       Date:  2020-08-14       Impact factor: 2.884

Review 8.  Genetic Alterations of TRAF Proteins in Human Cancers.

Authors:  Sining Zhu; Juan Jin; Samantha Gokhale; Angeli M Lu; Haiyan Shan; Jianjun Feng; Ping Xie
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

9.  Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.

Authors:  Yong-Pyo Lee; Jung Yong Hong; Sang Eun Yoon; Junhun Cho; Joon-Ho Shim; Yeonghak Bang; Won Seog Kim; Seok Jin Kim
Journal:  Cancer Manag Res       Date:  2021-05-28       Impact factor: 3.989

Review 10.  Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era.

Authors:  Eri Ishikawa; Masanao Nakamura; Akira Satou; Kazuyuki Shimada; Shotaro Nakamura
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.